TY - JOUR
T1 - Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere
T2 - Is It “Blowin’ in the Wind”?
AU - Blum, Kenneth
AU - McLaughlin, Thomas
AU - Bowirrat, Abdalla
AU - Modestino, Edward J.
AU - Baron, David
AU - Gomez, Luis Llanos
AU - Ceccanti, Mauro
AU - Braverman, Eric R.
AU - Thanos, Panayotis K.
AU - Cadet, Jean Lud
AU - Elman, Igor
AU - Badgaiyan, Rajendra D.
AU - Jalali, Rehan
AU - Green, Richard
AU - Simpatico, Thomas A.
AU - Gupta, Ashim
AU - Gold, Mark S.
N1 - Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2
Y1 - 2022/2
N2 - Reward Deficiency Syndrome (RDS) encompasses many mental health disorders, including a wide range of addictions and compulsive and impulsive behaviors. Described as an octopus of behavioral dysfunction, RDS refers to abnormal behavior caused by a breakdown of the cascade of reward in neurotransmission due to genetic and epigenetic influences. The resultant reward neurotransmission deficiencies interfere with the pleasure derived from satisfying powerful human physiological drives. Epigenetic repair may be possible with precision gene-guided therapy using formulations of KB220, a nutraceutical that has demonstrated pro-dopamine regulatory function in animal and human neuroimaging and clinical trials. Recently, large GWAS studies have revealed a significant dopaminergic gene risk polymorphic allele overlap between depressed and schizophrenic cohorts. A large volume of literature has also identified ADHD, PTSD, and spectrum disorders as having the known neurogenetic and psychological underpinnings of RDS. The hypothesis is that the true phenotype is RDS, and behavioral disorders are endophenotypes. Is it logical to wonder if RDS exists everywhere? Although complex, “the answer is blowin’ in the wind,” and rather than intangible, RDS may be foundational in species evolution and survival, with an array of many neurotransmitters and polymorphic loci influencing behavioral functionality.
AB - Reward Deficiency Syndrome (RDS) encompasses many mental health disorders, including a wide range of addictions and compulsive and impulsive behaviors. Described as an octopus of behavioral dysfunction, RDS refers to abnormal behavior caused by a breakdown of the cascade of reward in neurotransmission due to genetic and epigenetic influences. The resultant reward neurotransmission deficiencies interfere with the pleasure derived from satisfying powerful human physiological drives. Epigenetic repair may be possible with precision gene-guided therapy using formulations of KB220, a nutraceutical that has demonstrated pro-dopamine regulatory function in animal and human neuroimaging and clinical trials. Recently, large GWAS studies have revealed a significant dopaminergic gene risk polymorphic allele overlap between depressed and schizophrenic cohorts. A large volume of literature has also identified ADHD, PTSD, and spectrum disorders as having the known neurogenetic and psychological underpinnings of RDS. The hypothesis is that the true phenotype is RDS, and behavioral disorders are endophenotypes. Is it logical to wonder if RDS exists everywhere? Although complex, “the answer is blowin’ in the wind,” and rather than intangible, RDS may be foundational in species evolution and survival, with an array of many neurotransmitters and polymorphic loci influencing behavioral functionality.
KW - Dopamine
KW - Genetic addiction risk severity (GARS) test
KW - Hypodopaminergia
KW - Pro-dopamine regulation (KB220)
UR - http://www.scopus.com/inward/record.url?scp=85125293962&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/jpm12020321
DO - https://doi.org/10.3390/jpm12020321
M3 - مقالة
SN - 2075-4426
VL - 12
JO - Journal of Personalized Medicine
JF - Journal of Personalized Medicine
IS - 2
M1 - 321
ER -